CCM
TNGX icon

Cinctive Capital Management’s Tango Therapeutics TNGX Stock Holding History

Cinctive Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Sell
45,903
-176,208
-79% -$4.36M 0.05% 295
2026
Q1 		$4.65M Buy
+222,111
New +$3.09M 0.3% 111

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Cinctive Capital Management's TNGX Position: Q2 2026 in Review

Cinctive Capital Management reduced its Tango Therapeutics (TNGX) stake by 79% in Q2 2026, selling an estimated $4.36M and leaving 45,903 shares worth $1.43M. The position accounts for 0.05% of the portfolio, ranked #295.

Cinctive Capital Management first reported a position in TNGX in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.65M in Q1 2026. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Cinctive Capital Management held 45,903 shares of Tango Therapeutics worth $1.43M as of Q2 2026.
  • Cinctive Capital Management sold 176,208 Tango Therapeutics shares in Q2 2026, an estimated $4.36M.
  • Tango Therapeutics made up 0.05% of Cinctive Capital Management's portfolio in Q2 2026, its #295 holding.
  • Cinctive Capital Management first reported a position in Tango Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Cinctive Capital Management's Tango Therapeutics position peaked at $4.65M in Q1 2026.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.